Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 52 |
|
|||||
| News | - | ||||||
| Day High | 3.07 | Low High |
|||||
| Day Low | 3.07 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Acasti Pharma Inc | ACST | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 3.07 | 09:38:04 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.07 | 3.07 | 3.07 | 3.07 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 10 | 52 | - | 1.72 - 3.84 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 09:42:36 | 1 | $ 3.075 | USD |
Acasti Pharma Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 5.45M | 9.40M | - | 0 | -42.43M | -4.51 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Acasti Pharma News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ACST Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.40 | 3.415 | 3.06 | 3.27 | 12,276 | -0.33 | -9.71% |
| 1 Month | 3.40 | 3.50 | 3.06 | 3.39 | 30,713 | -0.33 | -9.71% |
| 3 Months | 2.39 | 3.59 | 2.25 | 3.21 | 27,394 | 0.68 | 28.45% |
| 6 Months | 2.64 | 3.59 | 1.98 | 2.89 | 24,383 | 0.43 | 16.29% |
| 1 Year | 2.82 | 3.84 | 1.72 | 2.90 | 47,338 | 0.25 | 8.87% |
| 3 Years | 2.46 | 17.6352 | 1.72 | 3.87 | 1,632,299 | 0.61 | 24.80% |
| 5 Years | 5.6706 | 18.48 | 1.026 | 4.18 | 4,913,943 | -2.60 | -45.86% |
Acasti Pharma Description
| Acasti Pharma Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. Its novel drug delivery technologies have the potential to improve the performance of marketed drugs by achieving faster onset of action, enhanced efficacy, reduced side effects, and more convenient drug delivery all which could help to increase treatment compliance and improve patient outcomes. |
